Helen Torley, PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO), sold 89,900 shares at $74.88 ($6.9M) on 2026-02-03, disclosed to the SEC on 2026-02-05.
Seasonal sale ($6.9M) by PRESIDENT AND CEO — this insider has traded HALO in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.88 | 2,551 | $191K | 2.8% |
| 2 | $74.88 | 2,551 | $191K | 2.8% |
| 3 | $75.94 | 9,659 | $734K | 10.6% |
| 4 | $75.94 | 9,659 | $734K | 10.6% |
| 5 | $76.73 | 7,790 | $598K | 8.6% |
| 6 | $76.73 | 7,790 |
| $598K |
| 8.6% |
| 7 | $76.94 | 9,900 | $762K | 11.0% |
| 8 | $76.94 | 9,900 | $762K | 11.0% |
| 9 | $77.54 | 10,100 | $783K | 11.3% |
| 10 | $78.38 | 5,376 | $421K | 6.1% |
| 11 | $78.38 | 5,376 | $421K | 6.1% |
| 12 | $78.94 | 4,624 | $365K | 5.3% |
| 13 | $78.94 | 4,624 | $365K | 5.3% |
| Total | $77.02 avg | 89,900 | $6.9M | 100% |
| Filing → |
| HALO | SELL | 2026-08-19 | $6.3M | — | Filing → |
| HALO | SELL | 2026-07-09 | $153K | — | Filing → |
| HALO | SELL | 2026-06-03 | $3.4M | — | Filing → |